The Food and Drug Administration (“FDA”) has released Pfizer’s report on adverse events to its Covid injection for the first two-and-a-half months since post-emergency authorisation.  Over this period Pfizer had received more than 42,000 reports, mostly from the United States.  Almost 30,000 of these adverse event reports were from women and 26,000 related to nervous … Continue reading PFIZER CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048